Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Equity Ratio (2016 - 2025)

Biomerica's Equity Ratio history spans 15 years, with the latest figure at 0.74 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 4.54% year-over-year to 0.74; the TTM value through Nov 2025 reached 0.74, up 4.54%, while the annual FY2025 figure was 0.69, 3.05% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.74 at Biomerica, down from 0.75 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.81 in Q3 2023 and bottomed at 0.56 in Q1 2022.
  • The 5-year median for Equity Ratio is 0.74 (2025), against an average of 0.73.
  • The largest annual shift saw Equity Ratio surged 39.37% in 2021 before it tumbled 30.03% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 0.6 in 2021, then grew by 21.64% to 0.73 in 2022, then rose by 8.47% to 0.79 in 2023, then fell by 11.35% to 0.7 in 2024, then grew by 4.54% to 0.74 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Equity Ratio are 0.74 (Q4 2025), 0.75 (Q3 2025), and 0.69 (Q2 2025).